Showing results (11-20 of 46) with videos related to
Sort By:
Pageof 5
Diagnostics (Basel, Switzerland)|July 2, 2021
Cell-Secreted Vesicles: Novel Opportunities in Cancer Diagnosis, Monitoring and TreatmentCristina Catoni, Veronica Di Paolo, Elisabetta Rossi, et al.European Journal of Pharmacology|June 24, 2008
Carteolol, a non-conventional partial agonist of beta(1)-adrenoceptors, relaxes phenylephrine-constricted rat aorta through antagonism at alpha(1)-adrenoceptorsMaura Floreani, Luigi Quintieri, Katia Varani, et al.Anti-Cancer Agents in Medicinal Chemistry|June 23, 2009
Glutathione transferases as targets for cancer therapyPaolo Ruzza, Antonio Rosato, Carlo Riccardo Rossi, et al.Chemical Research in Toxicology|January 10, 2017
Virtual Cross-Linking of the Active Nemorubicin Metabolite PNU-159682 to Double-Stranded DNAMatteo Scalabrin, Luigi Quintieri, Manlio Palumbo, et al.European Journal of Pharmacology|July 1, 2008
Comparison of the binding affinity of CGP-12177A at recombinant rat alpha(1D)-adrenoceptors expressed in BHK-21 cell membranes and alpha(1)-adrenoceptors present in rat cerebral cortex membranesMaura Floreani, Katia Varani, Luigi Quintieri, et al.Journal of Pharmacological and Toxicological Methods|May 22, 2024
A genetic algorithm-based approach for the prediction of metabolic drug-drug interactions involving CYP2C8 or CYP2B6Veronica Di Paolo, Francesco Maria Ferrari, Davide Veronese, et al.Frontiers in Oncology|January 28, 2022
Determinants of Drug Resistance in B-Cell Non-Hodgkin Lymphomas: The Case of Lymphoplasmacytic Lymphoma/Waldenström MacroglobulinemiaFrancesco Piazza, Veronica Di Paolo, Greta Scapinello, et al.Chemico-Biological Interactions|May 1, 2025
A genetic algorithm-based approach for quantitative prediction of drug-drug interactions caused by cytochrome P450 3A inhibitors and inducers in dogs and catsVeronica Di Paolo, Francesco Maria Ferrari, Italo Poggesi, et al.Pharmaceuticals (Basel, Switzerland)|June 26, 2026
A Genetic Algorithm-Based Approach for Quantitative Prediction of Drug-Drug Interactions Caused by Cytochrome P450 3A Inhibition or Induction in HorsesVeronica Di Paolo, Francesco Maria Ferrari, Italo Poggesi, et al.Surgical Oncology Clinics of North America|October 22, 2003
Pharmacokinetics of intraperitoneal cisplatin and doxorubicinCarlo Riccardo Rossi, Simone Mocellin, Pierluigi Pilati, et al.Pageof 5